Table 5 Typing data for C. difficile isolated from the general environment and patients
Hospital (n) | Ribotype | % per hospital (n) | Toxinotype | Toxin genes | Visit number (n) | |||
|---|---|---|---|---|---|---|---|---|
Environment: | Â | Â | Â | Â | 1 | 2 | 3 | 4 |
A (6) | 027 | 16.7% (1) | III | tcdA, tcdB, cdtA | 0 | 0 | 0 | 1 |
| Â | 078 | 16.7% (1) | V | tcdA, tcdB, cdtA | 1 | 0 | 0 | 0 |
| Â | MOH-AD | 16.7% (1) | III | tcdA, tcdB, cdtA | 0 | 0 | 0 | 1 |
| Â | MOH-O | 16.7% (1) | 0 | tcdA, tcdB | 0 | 0 | 0 | 1 |
| Â | GRH-A | 16.7% (1) | Not tested | None | 0 | 0 | 0 | 1 |
| Â | OVC-J | 16.7% (1) | Not tested | None | 0 | 0 | 0 | 1 |
B (2) | 027 | 50.0% (1) | III | tcdA, tcdB, cdtA | 0 | 0 | 1 | 0 |
| Â | MOH-C | 50.0% (1) | IX | tcdA, tcdB, cdtA | 0 | 1 | 0 | 0 |
C (5) | MOH-T | 80.0% (4) | 0 | tcdA, tcdB | 0 | 0 | 1 | 3 |
| Â | OVC-J | 20.0% (1) | Not tested | None | 0 | 0 | 0 | 1 |
Patients: | Â | Â | Â | Â | Â | Â | Â | Â |
C (5) | MOH-AG | 20.0% (1) | 0 | tcdA, tcdB | 0 | 0 | 1 | 0 |
| Â | MOH-T | 20.0% (1) | 0 | tcdA, tcdB | 0 | 0 | 1 | 0 |
| Â | MOH-V | 20.0% (1) | 0 | tcdA, tcdB | 0 | 1 | 0 | 0 |
| Â | MOH-Y | 20.0% (1) | III | tcdA, tcdB, cdtA | 0 | 0 | 1 | 0 |
| Â | OS-A | 20.0% (1) | Not tested | None | 0 | 0 | 1 | 0 |